Related Experiment Video
Updated: Feb 12, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP
1Department of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California-San Francisco, San Francisco, CA 94158, USA.
Abstract:
The single most frequent cancer-causing mutation across all heterotrimeric G proteins is R201C in Gαs. The current model explaining the gain-of-function activity of the R201 mutations is through the loss of GTPase activity and resulting inability to switch off to the GDP state. Here, we find that the R201C mutation can bypass the need for GTP binding by directly activating GDP-bound Gαs through stabilization of an intramolecular hydrogen bond network. Having found that a gain-of-function mutation can convert GDP into an activator, we postulated that a reciprocal mutation might disrupt the normal role of GTP. Indeed, we found R228C, a loss-of-function mutation in Gαs that causes pseudohypoparathyroidism type 1a (PHP-Ia), compromised the adenylyl cyclase-activating activity of Gαs bound to a non-hydrolyzable GTP analog. These findings show that disease-causing mutations in Gαs can subvert the canonical roles of GDP and GTP, providing new insights into the regulation mechanism of G proteins.
Insights
Cancer-causing Gαs mutations, like R201C, activate the protein independently of GTP. A reciprocal mutation, R228C, disrupts GTP
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Signaling
Background:
- Heterotrimeric G proteins are crucial signal transducers.
- Mutations in Gαs, particularly R201C, are frequently linked to cancer.
- The canonical model posits GTPase activity regulates Gαs function.
Purpose of the Study:
- To investigate the mechanism of gain-of-function mutations in Gαs.
- To explore how mutations affect GTP and GDP binding and activation.
- To understand the molecular basis of Gαs-related diseases.
Main Methods:
- Site-directed mutagenesis to create R201C and R228C mutations in Gαs.
- Biochemical assays to measure GTPase activity and adenylyl cyclase activation.
- Analysis of Gαs interaction with GTP and GDP analogs.
Main Results:
- The R201C mutation activates GDP-bound Gαs by stabilizing an intramolecular hydrogen bond network, bypassing GTP binding.
- The R228C mutation, associated with pseudohypoparathyroidism type 1a (PHP-Ia), impairs the adenylyl cyclase-activating function of GTP-bound Gαs.
- These findings demonstrate that disease-associated mutations can alter the fundamental roles of GDP and GTP in Gαs regulation.
Conclusions:
- Gαs mutations can subvert the canonical GDP/GTP switch mechanism.
- Gain-of-function mutations can activate Gαs even in the GDP-bound state.
- Loss-of-function mutations can interfere with GTP-mediated activation, offering new therapeutic targets.
Related Concept Videos
G-protein Coupled Receptors
Mechanical Protein Functions
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Role of Proteins in the Human Body
Viral Mutations

